Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | F2 | P00734 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 5/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 2/20 | 0.41 |
| ▸ | CES1 | P23141 | 2/20 | 0.41 |
| ▸ | DAO | P14920 | 1/20 | 0.41 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6871550 | 0.98 | LMNA (0.61) | LMNAF2TSHRTDP1ALDH1A1 | |
| Benzoyl Peroxide SCHEMBL28119977 | 0.90 | LMNA (0.68) | LMNAF2TSHRTDP1ALDH1A1 | |
| SCHEMBL6684579 | 0.85 | LMNA (0.67) | LMNAF2TSHRTDP1ALDH1A1 | |
| Benzoyl Peroxide SCHEMBL28088598 | 0.83 | LMNA (0.77) | LMNAF2TSHRTDP1ALDH1A1 | |
| Benzoyl Peroxide SCHEMBL28866245 | 0.83 | LMNA (0.77) | LMNAF2TSHRTDP1ALDH1A1 | |
| SCHEMBL20885264 | 0.82 | LMNA (0.61) | LMNAF2TSHRTDP1ALDH1A1 | |
| Benzoyl Peroxide SCHEMBL2099012 | 0.82 | LMNA (0.68) | LMNAF2TSHRTDP1ALDH1A1 | |
| SCHEMBL2313363 | 0.80 | LMNA (0.59) | LMNAF2TSHRTDP1ALDH1A1 | |
| SCHEMBL3018658 | 0.80 | F2 (0.59) | LMNAF2TSHRTDP1ALDH1A1 | |
| SCHEMBL3026705 | 0.80 | F2 (0.59) | LMNAF2TSHRTDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1115373-B1 | ORAL COMPOSITION WITH AN IMPROVED TEETH WHITENING EFFECT | UNILEVER NV (NL) | 2004-12-22 | — | — | EP | claimed |
| EP-0675801-B1 | PHENOLIC ACID SULFATE ESTERS FOR PREVENTION OF MARINE BIOFOULING | ARCH DEV CORP (US) | 2002-04-03 | — | — | EP | claimed |
| EP-1115373-A1 | ORAL COMPOSITION WITH AN IMPROVED TEETH WHITENING EFFECT | UNILEVER N.V. (NL) | 2001-07-18 | — | — | EP | claimed |
| US-6165448-A | Oral composition with an improved teeth whitening effect | CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO, INC. (US) | 2000-12-26 | — | — | US | claimed |
| WO-2000018366-A1 | ORAL COMPOSITION WITH AN IMPROVED TEETH WHITENING EFFECT | UNILEVER N.V. (NL) | 2000-04-06 | — | — | WO | claimed |
| US-5607741-A | Phenolic acid sulfate esters for prevention of marine biofouling | ARCH DEVELOPMENT CORPORATION (US) | 1997-03-04 | — | — | US | claimed |
| US-5384176-A | Phenolic acid sulfate esters for prevention of marine biofouling | LEVIN, IRA | 1995-01-24 | — | — | US | claimed |
| US-11779013-B2 | Stabilized peroxyacid solutions | EVONIK CORPORATION (US) | 2023-10-10 | — | — | US | disclosed |
| CN-112512320-B | Stabilized peroxyacid solutions | 赢创有限公司 | 2022-07-08 | — | — | CN | disclosed |
| US-20210219543-A1 | STABILIZED PEROXYACID SOLUTIONS | EVONIK CORPORATION (US) | 2021-07-22 | — | — | US | disclosed |
| EP-3829306-A1 | STABILIZED PEROXYACID SOLUTIONS | Evonik Corporation (US) | 2021-06-09 | — | — | EP | disclosed |
| CN-112512320-A | Stabilized peroxyacid solutions | 赢创有限公司 | 2021-03-16 | — | — | CN | disclosed |
| WO-2020028657-A1 | STABILIZED PEROXYACID SOLUTIONS | EVONIK CORPORATION (US) | 2020-02-06 | — | — | WO | disclosed |
| US-4704404-A | IMPACT AND STORAGE STABLE | INTEROX CHEMICALS LIMITED (GB) | 1987-11-03 | — | — | US | disclosed |
| EP-0233730-A2 | Concentrated liquid compositions containing a peroxygen compound | Interox Chemicals Limited (GB) | 1987-08-26 | — | — | EP | disclosed |
| EP-0124968-B1 | PEROXYGEN COMPOUNDS, A PROCESS FOR THEIR MANUFACTURE, AND PROCESSES AND COMPOSITIONS FOR THEIR USE IN BLEACHING, DISINFECTING, SANITISING OR WASHING | Interox Chemicals Limited (GB) | 1987-05-20 | — | — | EP | disclosed |
| EP-0124968-A1 | Peroxygen compounds, a process for their manufacture, and processes and compositions for their use in bleaching, disinfecting, sanitising or washing | Interox Chemicals Limited (GB) | 1984-11-14 | — | — | EP | disclosed |
| US-4393242-A | Process for preparing methylvanillyl ketone from isoeugenol | MERCK & CO., INC. (US) | 1983-07-12 | — | — | US | disclosed |
| US-4337360-A | EPOXIDATION OF PROTECTED ISOEUGENOL FOLLOWED BY ACID HYDROLYSIS | MERCK & CO., INC. (US) | 1982-06-29 | — | — | US | disclosed |
| US-4273943-A | OXIDATION OF ISOEUGENOL WITH ACID HYDROLYSIS | MERCK & CO., INC. (US) | 1981-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11779013-B2 | Stabilized peroxyacid solutions | PGD, ACMSD, ALAD | LMNA 3905/4885F2 620/4885TSHR 2887/4885 |
| US-20210219543-A1 | STABILIZED PEROXYACID SOLUTIONS | PGD, ACMSD, ALAD | LMNA 3905/4885F2 620/4885TSHR 2887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.